Testosterone Replacement Therapy in the Aged Male: Monitoring Patients' Quality of Life Utilizing Scoring Systems

Overview

Journal Int J Gen Med

Publisher Dove Medical Press

Specialty General Medicine

Date 2022 Sep 15

PMID 36105846

Authors

Georgios Tsampoukas

Karl H Pang

Athanasios Papatsoris

Mohamad Moussa

Saiful Miah

Affiliations

Soon will be listed here.

Abstract

Hypogonadism has been associated with significant deterioration of well-being. In the aging male, late-onset hypogonadism affects sexual life, mental health, levels of energy, lower urinary tract symptoms and, therefore, quality of life may be found significantly deteriorated. Testosterone replacement or supplementation therapy has been found efficient to reverse the adverse effects of hypogonadism and improve quality of life. Scales and questionnaires assessing the general health, urinary symptoms, sexual health, and cognition can provide a thorough assessment of the clinical syndrome, optimize treatment, assist the follow-up, and facilitate referrals to other specialties depending on the chief complaint. A systematic assessment might combine several tools, but the optimal ones and the exact usage is unknown. In this narrative review, we are flipping through the literature presenting the available tools per domain for the assessment of quality of life in men on testosterone replacement therapy and we discuss the optimal usage.

References

Corona G, Petrone L, Paggi F, Lotti F, Boddi V, Fisher A . Sexual dysfunction in subjects with Klinefelter's syndrome. Int J Androl. 2009; 33(4):574-80. DOI: 10.1111/j.1365-2605.2009.00986.x. View

Tharakan T, Miah S, Jayasena C, Minhas S . Investigating the basis of sexual dysfunction during late-onset hypogonadism. F1000Res. 2019; 8. PMC: 6436191. DOI: 10.12688/f1000research.16561.1. View

Fink J, Hackney A, Matsumoto M, Maekawa T, Horie S . Mobility and Biomechanical Functions in the Aging Male: Testosterone and the Locomotive Syndrome. Aging Male. 2018; 23(5):403-410. DOI: 10.1080/13685538.2018.1504914. View

Lee K, Berman N, Alexander G, Hull L, Swerdloff R, Wang C . A simple self-report diary for assessing psychosexual function in hypogonadal men. J Androl. 2003; 24(5):688-98. DOI: 10.1002/j.1939-4640.2003.tb02728.x. View

Khera M, Bhattacharya R, Blick G, Kushner H, Nguyen D, Miner M . Improved sexual function with testosterone replacement therapy in hypogonadal men: real-world data from the Testim Registry in the United States (TRiUS). J Sex Med. 2011; 8(11):3204-13. DOI: 10.1111/j.1743-6109.2011.02436.x. View

Holmang S, Marin P, Lindstedt G, Hedelin H . Effect of long-term oral testosterone undecanoate treatment on prostate volume and serum prostate-specific antigen concentration in eugonadal middle-aged men. Prostate. 1993; 23(2):99-106. DOI: 10.1002/pros.2990230203. View

Tang W, Niu H, Yang Y, Li H, Liu H, Zhang J . Efficacy and safety of transurethral resection of bladder tumor for superficial bladder cancer. Am J Transl Res. 2021; 13(11):12860-12867. PMC: 8661148. View

Okada K, Miyake H, Ishida T, Sumii K, Enatsu N, Chiba K . Improved Lower Urinary Tract Symptoms Associated With Testosterone Replacement Therapy in Japanese Men With Late-Onset Hypogonadism. Am J Mens Health. 2016; 12(5):1403-1408. PMC: 6142172. DOI: 10.1177/1557988316652843. View

Jaschke N, Wang A, Hofbauer L, Rauner M, Rachner T . Late-onset hypogonadism: Clinical evidence, biological aspects and evolutionary considerations. Ageing Res Rev. 2021; 67:101301. PMC: 8043243. DOI: 10.1016/j.arr.2021.101301. View

10.

Aydogan U, Aydogdu A, Akbulut H, Sonmez A, Yuksel S, Basaran Y . Increased frequency of anxiety, depression, quality of life and sexual life in young hypogonadotropic hypogonadal males and impacts of testosterone replacement therapy on these conditions. Endocr J. 2012; 59(12):1099-105. DOI: 10.1507/endocrj.ej12-0134. View

11.

Ko Y, Moon D, Moon K . Testosterone replacement alone for testosterone deficiency syndrome improves moderate lower urinary tract symptoms: one year follow-up. World J Mens Health. 2013; 31(1):47-52. PMC: 3640152. DOI: 10.5534/wjmh.2013.31.1.47. View

12.

Paduch D, Polzer P, Ni X, Basaria S . Testosterone Replacement in Androgen-Deficient Men With Ejaculatory Dysfunction: A Randomized Controlled Trial. J Clin Endocrinol Metab. 2015; 100(8):2956-62. DOI: 10.1210/jc.2014-4434. View

13.

Taniguchi H, Shimada S, Kinoshita H . Testosterone Therapy for Late-Onset Hypogonadism Improves Erectile Function: A Systematic Review and Meta-Analysis. Urol Int. 2021; 106(6):539-552. DOI: 10.1159/000520135. View

14.

Coward R, Simhan J, Carson 3rd C . Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy. BJU Int. 2009; 103(9):1179-83. DOI: 10.1111/j.1464-410X.2008.08240.x. View

15.

Moncada I . Testosterone and men's quality of life. Aging Male. 2006; 9(4):189-93. DOI: 10.1080/13685530601003180. View

16.

Dunlop E, Ferguson A, Mueller T, Baillie K, Clarke J, Laskey J . What matters to patients and clinicians when discussing the impact of cancer medicines on health-related quality of life? Consensus-based mixed methods approach in prostate cancer. Support Care Cancer. 2021; 30(4):3141-3150. PMC: 8857102. DOI: 10.1007/s00520-021-06724-6. View

17.

Shigehara K, Konaka H, Koh E, Izumi K, Kitagawa Y, Mizokami A . Effects of testosterone replacement therapy on nocturia and quality of life in men with hypogonadism: a subanalysis of a previous prospective randomized controlled study in Japan. Aging Male. 2015; 18(3):169-74. DOI: 10.3109/13685538.2015.1038990. View

18.

Kovac J, Rajanahally S, Smith R, Coward R, Lamb D, Lipshultz L . Patient satisfaction with testosterone replacement therapies: the reasons behind the choices. J Sex Med. 2013; 11(2):553-62. PMC: 3946859. DOI: 10.1111/jsm.12369. View

19.

Huhtaniemi I . Andropause--lessons from the European Male Ageing Study. Ann Endocrinol (Paris). 2014; 75(2):128-31. DOI: 10.1016/j.ando.2014.03.005. View

20.

Rosen R, Wu F, Behre H, Porst H, Meuleman E, Maggi M . Quality of Life and Sexual Function Benefits of Long-Term Testosterone Treatment: Longitudinal Results From the Registry of Hypogonadism in Men (RHYME). J Sex Med. 2017; 14(9):1104-1115. DOI: 10.1016/j.jsxm.2017.07.004. View